[Federal Register Volume 71, Number 14 (Monday, January 23, 2006)]
[Notices]
[Page 3546]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-715]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 18, 2005, and published in the Federal 
Register on August 19, 2005, (70 FR 48780), Sigma Aldrich Research 
Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760, 
made application by letter to the Drug Enforcement Administration (DEA) 
to be registered as a bulk manufacturer of N-Benzylpiperazine (7493), a 
basic class of controlled substance listed in Schedules I.
    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. Sec.  823(a) and determined that the 
registration of Sigma Aldrich Research, Biochemicals, Inc. to 
manufacture the listed basic classes of controlled substances is 
consistent with the public interest at this time. DEA has investigated 
Sigma Aldrich Research, Biochemicals, Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic class of controlled substance listed.

    Dated: January 11, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E6-715 Filed 1-20-06; 8:45 am]
BILLING CODE 4410-09-P